Sarcopenia Is Independently Associated with Cardiovascular Disease in Older Korean Adults: The Korea National Health and Nutrition Examination Survey (KNHANES) from 2009

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Chin, Sang Ouk ^a   Rhee, Sang Youl ^a   Chon, Suk ^a   Hwang, You Cheol ^b   Jeong, In Kyung ^b   Oh, Seungjoon ^a   Ahn, Kyu Jeung ^b   Chung, Ho Yeon ^b   Woo, Jeong taek ^a   Kim, Sung Woon ^a   Kim, Jin Woo ^a   Kim, Young Seol ^a   Ahn, Hong Yup ^c  

^a Kyung Hee University Hospital   (South Korea)

^b Kyung Hee University College of Medicine   (South Korea)

^c Dongguk University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; CREATININE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NON HIGH DENSITY LIPOPROTEIN CHOLESTEROL; UNCLASSIFIED DRUG;

AGE; AGED; ARTICLE; BODY MASS; BODY WEIGHT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; ETHNIC GROUP; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; KIDNEY FUNCTION; KOREAN; MAJOR CLINICAL STUDY; MALE; MUSCLE ATROPHY; MUSCLE MASS; OBESITY; PREVALENCE; RISK ASSESSMENT; SMOKING; WAIST CIRCUMFERENCE;

AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; KOREA; MALE; RISK FACTORS; SARCOPENIA;

EID: 84875360599     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0060119     Document Type: Article

References (35)

1. Woodrow G, (2009) Body composition analysis techniques in the aged adult: indications and limitations. Curr Opin Clin Nutr Metab Care 12: 8-14.
2. Narici MV, Maffulli N, (2010) Sarcopenia: characteristics, mechanisms and functional significance. Br Med Bull 95: 139-159.
3. Janssen I, Heymsfield SB, Wang ZM, Ross R, (2000) Skeletal muscle mass and distribution in 468 men and women aged 18-88 yr. J Appl Physiol 89: 81-88.
4. Janssen I, Heymsfield SB, Ross R, (2002) Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc 50: 889-896.
5. Baumgartner RN, Koehler KM, Gallagher D, Romero L, Heymsfield SB, et al. (1998) Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 147: 755-763.
6. Newman AB, Kupelian V, Visser M, Simonsick E, Goodpaster B, et al. (2003) Sarcopenia: alternative definitions and associations with lower extremity function. J Am Geriatr Soc 51: 1602-1609.
7. Delmonico MJ, Harris TB, Lee JS, Visser M, Nevitt M, et al. (2007) Alternative definitions of sarcopenia, lower extremity performance, and functional impairment with aging in older men and women. J Am Geriatr Soc 55: 769-774.
8. Wang J, Heymsfield SB, Aulet M, Thornton JC, Pierson RN Jr, (1989) Body fat from body density: underwater weighing vs. dual-photon absorptiometry. Am J Physiol 256: E829-834.
9. Stenholm S, Harris TB, Rantanen T, Visser M, Kritchevsky SB, et al. (2008) Sarcopenic obesity: definition, cause and consequences. Curr Opin Clin Nutr Metab Care 11: 693-700.
10. Lang T, Streeper T, Cawthon P, Baldwin K, Taaffe DR, et al. (2010) Sarcopenia: etiology, clinical consequences, intervention, and assessment. Osteoporos Int 21: 543-559.
11. Lexell J, Downham DY, (1991) The occurrence of fibre-type grouping in healthy human muscle: a quantitative study of cross-sections of whole vastus lateralis from men between 15 and 83 years. Acta Neuropathol 81: 377-381.
12. Schrager MA, Metter EJ, Simonsick E, Ble A, Bandinelli S, et al. (2007) Sarcopenic obesity and inflammation in the InCHIANTI study. J Appl Physiol 102: 919-925.
13. Karakelides H, Nair KS, (2005) Sarcopenia of aging and its metabolic impact. Curr Top Dev Biol 68: 123-148.
14. Sanada K, Miyachi M, Tanimoto M, Yamamoto K, Murakami H, et al. (2010) A cross-sectional study of sarcopenia in Japanese men and women: reference values and association with cardiovascular risk factors. Eur J Appl Physiol 110: 57-65.
15. Aubertin-Leheudre M, Lord C, Goulet ED, Khalil A, Dionne IJ, (2006) Effect of sarcopenia on cardiovascular disease risk factors in obese postmenopausal women. Obesity (Silver Spring) 14: 2277-2283.
16. Davison KK, Ford ES, Cogswell ME, Dietz WH, (2002) Percentage of body fat and body mass index are associated with mobility limitations in people aged 70 and older from NHANES III. J Am Geriatr Soc 50: 1802-1809.
17. Goulet ED, Lord C, Chaput JP, Aubertin-Leheudre M, Brochu M, et al. (2007) No difference in insulin sensitivity between healthy postmenopausal women with or without sarcopenia: a pilot study. Appl Physiol Nutr Metab 32: 426-433.
18. Oterdoom LH, Gansevoort RT, Schouten JP, de Jong PE, Gans RO, et al. (2009) Urinary creatinine excretion, an indirect measure of muscle mass, is an independent predictor of cardiovascular disease and mortality in the general population. Atherosclerosis 207: 534-540.
19. Metter EJ, Talbot LA, Schrager M, Conwit R, (2002) Skeletal muscle strength as a predictor of all-cause mortality in healthy men. J Gerontol A Biol Sci Med Sci 57: B359-365.
20. Heymsfield SB, Smith R, Aulet M, Bensen B, Lichtman S, et al. (1990) Appendicular skeletal muscle mass: measurement by dual-photon absorptiometry. Am J Clin Nutr 52: 214-218.
21. Schoeller DA, Tylavsky FA, Baer DJ, Chumlea WC, Earthman CP, et al. (2005) QDR 4500A dual-energy X-ray absorptiometer underestimates fat mass in comparison with criterion methods in adults. Am J Clin Nutr 81: 1018-1025.
22. Kelly TL, Wilson KE, Heymsfield SB, (2009) Dual energy X-Ray absorptiometry body composition reference values from NHANES. PLoS One 4: e7038.
23. Lim S, Kim JH, Yoon JW, Kang SM, Choi SH, et al. (2010) Sarcopenic obesity: prevalence and association with metabolic syndrome in the Korean Longitudinal Study on Health and Aging (KLoSHA). Diabetes Care 33: 1652-1654.
24. WHO Expert Consultation, (2004) Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363: 157-163.
25. Standards of medical care in diabetes 2011. In: Diabetes Care. 2011/01/14 ed: American Diabetes Association; S11-61.
26. Levy JC, Matthews DR, Hermans MP, (1998) Correct Homeostasis Model Assessment (HOMA) Evaluation Uses the Computer Program. Diabetes Care 21: 2191-2192.
27. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, et al. (2005) Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Executive summary. Cardiol Rev 13: 322-327.
28. Gallagher D, Visser M, De Meersman RE, Sepulveda D, Baumgartner RN, et al. (1997) Appendicular skeletal muscle mass: effects of age, gender, and ethnicity. J Appl Physiol 83: 229-239.
29. Iannuzzi-Sucich M, Prestwood KM, Kenny AM, (2002) Prevalence of sarcopenia and predictors of skeletal muscle mass in healthy, older men and women. J Gerontol A Biol Sci Med Sci 57: M772-777.
30. Cohen HJ, Pieper CF, Harris T, Rao KM, Currie MS, (1997) The association of plasma IL-6 levels with functional disability in community-dwelling elderly. J Gerontol A Biol Sci Med Sci 52: M201-208.
31. Neels JG, Olefsky JM, (2006) Inflamed fat: what starts the fire? J Clin Invest 116: 33-35.
32. Myers J, Kaykha A, George S, Abella J, Zaheer N, et al. (2004) Fitness versus physical activity patterns in predicting mortality in men. Am J Med 117: 912-918.
33. Pedersen BK, Steensberg A, Fischer C, Keller C, Keller P, et al. (2003) Searching for the exercise factor: is IL-6 a candidate? J Muscle Res Cell Motil 24: 113-119.
34. Pedersen BK, (2010) Muscle-to-fat interaction: a two-way street? J Physiol 588: 21.
35. Cesari M, Kritchevsky SB, Baumgartner RN, Atkinson HH, Penninx BW, et al. (2005) Sarcopenia, obesity, and inflammation - results from the Trial of Angiotensin Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors study. Am J Clin Nutr 82: 428-434.